Coral Labs.

{
  "main_header": {
    "sid": 476417,
    "name": "Coral Labs.",
    "stock_name": "Coral Labs.",
    "full_name": "Coral Laboratories Ltd",
    "name_url": "stocks-analysis/coral-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "467.55",
    "chg": -3.25,
    "chgp": "-0.69%",
    "dir": -1,
    "prev_price": "470.80",
    "mcapval": "167.04 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524506,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE683E01017",
    "curr_date": "Feb 10",
    "curr_time": "",
    "bse_nse_vol": "771 ",
    "exc_status": "Active",
    "traded_date": "Feb 10, 2026",
    "traded_date_str": "2026 02 10",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/coral-labs-476417-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Coral Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-coral-laboratories-ltd-3825183",
        "imagepath": "",
        "date": "2026-02-06 23:18:12",
        "description": "The next results date for Coral Laboratories Ltd is scheduled for 13 February 2026...."
      },
      {
        "title": "Coral Laboratories Ltd Stock Rating Upgraded to Sell Amid Mixed Technical and Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-stock-rating-upgraded-to-sell-amid-mixed-technical-and-financial-signals-3817362",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CoralLaboratori_mojoScore_3817362.png",
        "date": "2026-02-03 08:12:46",
        "description": "Coral Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 2 February 2026, driven primarily by a shift in technical indicators. Despite persistent financial underperformance and weak long-term growth metrics, the stock’s technical outlook has improved from bearish to mildly bearish, prompting a reassessment of its near-term prospects."
      },
      {
        "title": "Coral Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-is-rated-strong-sell-3803933",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CoralLaboratori_mojoScore_3803933.png",
        "date": "2026-01-25 10:10:42",
        "description": "Coral Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Coral Laboratories Ltd Stock Hits 52-Week Low at Rs.415",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltd-stock-hits-52-week-low-at-rs415-3798539",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CoralLaboratori_priceRelatedfactors_3798539.png",
        "date": "2026-01-21 11:29:02",
        "description": "Shares of Coral Laboratories Ltd have declined to a fresh 52-week low of Rs.415 on 21 Jan 2026, marking a significant downturn amid persistent underperformance relative to the broader market and sector indices."
      },
      {
        "title": "Coral Laboratories Ltd Stock Falls to 52-Week Low of Rs.419",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltd-stock-falls-to-52-week-low-of-rs419-3790066",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CoralLaboratori_priceRelatedfactors_3790066.png",
        "date": "2026-01-12 12:00:17",
        "description": "Coral Laboratories Ltd has reached a new 52-week low of Rs.419, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and valuation metrics."
      },
      {
        "title": "Coral Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-is-rated-sell-3789639",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CoralLaboratori_mojoScore_3789639.png",
        "date": "2026-01-12 10:10:52",
        "description": "Coral Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Coral Laboratories Ltd’s 1.00% Weekly Gain Masks Underlying Weaknesses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltds-100-weekly-gain-masks-underlying-weaknesses-3780124",
        "imagepath": "",
        "date": "2026-01-04 12:44:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>29 Dec 2025:</strong> Stock opens at Rs.446.85, declines 1.11%</p>\n                    <p><strong>30 Dec 2025:</strong> Further decline to Rs.437.40 (-2.11%)</p>\n                    <p><strong>31 Dec 2025:</strong> Coral Laboratories hits 52-week low of Rs.429</p>\n                    <p><strong>1 Jan 2026:</strong> Downgraded to Strong Sell by MarketsMOJO</p>\n                    <p><strong>2 Jan 2026:</strong> Stock rebounds to Rs.456.35 (+3.32%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.446.85</div></div>\n                    <div class=\"stat-item\"..."
      },
      {
        "title": "Coral Laboratories Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3777106",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CoralLaboratori_mojoScore_3777106.png",
        "date": "2026-01-01 08:10:27",
        "description": "Coral Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 31 Dec 2025. This revision reflects deteriorating financial performance, unfavourable valuation metrics, and a shift towards bearish technical indicators, signalling heightened risk for investors."
      },
      {
        "title": "Coral Laboratories Ltd Stock Falls to 52-Week Low of Rs.429",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltd-stock-falls-to-52-week-low-of-rs429-3776281",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/CoralLaboratori_priceRelatedfactors_3776281.png",
        "date": "2025-12-31 11:17:50",
        "description": "Coral Laboratories Ltd touched a fresh 52-week low of Rs.429 today, marking a significant decline amid ongoing challenges in its financial performance and market positioning. Despite a modest intraday recovery, the stock remains below all key moving averages, reflecting persistent downward pressure."
      }
    ],
    "total": 146,
    "sid": "476417",
    "stock_news_url": "https://www.marketsmojo.com/news/coral-laboratories-476417"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting To Consider Financial Result For The Quarter And Nine Months Ended On December 31 2025",
      "datetime": "05-Feb-2026",
      "details": "Coral Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve Intimation of Board meeting to consider financial result for the quarter and nine months ended on December 31 2025 and other general business matter.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Jan-2026",
      "details": "Please find attached herewith Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 furnished by M/s. MUF Intime India Private Limited (formerly known as Link Intime India Private Limited) the Registrar and Share Transfer agent of the Company for the quarter ended December 31 2025. You are requested to take the same on record.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "30-Dec-2025",
      "details": "Sub: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations 2015 Reg: Intimation regarding Resignation of Company Secretary and Compliance Officer of the Company In compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we hereby inform you that Mrs. Dhwani Desai has tendered her resignation from the post of Company Secretary and Compliance Officer of the Company to pursue another career opportunity.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "13 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Coral Laboratories Ltd has declared <strong>15%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

When is the next results date for Coral Laboratories Ltd?

2026-02-06 23:18:12

The next results date for Coral Laboratories Ltd is scheduled for 13 February 2026....

Read full news article

Coral Laboratories Ltd Stock Rating Upgraded to Sell Amid Mixed Technical and Financial Signals

2026-02-03 08:12:46

Coral Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 2 February 2026, driven primarily by a shift in technical indicators. Despite persistent financial underperformance and weak long-term growth metrics, the stock’s technical outlook has improved from bearish to mildly bearish, prompting a reassessment of its near-term prospects.

Read full news article

Coral Laboratories Ltd is Rated Strong Sell

2026-01-25 10:10:42

Coral Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Coral Laboratories Ltd Stock Hits 52-Week Low at Rs.415

2026-01-21 11:29:02

Shares of Coral Laboratories Ltd have declined to a fresh 52-week low of Rs.415 on 21 Jan 2026, marking a significant downturn amid persistent underperformance relative to the broader market and sector indices.

Read full news article

Coral Laboratories Ltd Stock Falls to 52-Week Low of Rs.419

2026-01-12 12:00:17

Coral Laboratories Ltd has reached a new 52-week low of Rs.419, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial performance and valuation metrics.

Read full news article

Coral Laboratories Ltd is Rated Sell

2026-01-12 10:10:52

Coral Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article

Coral Laboratories Ltd’s 1.00% Weekly Gain Masks Underlying Weaknesses

2026-01-04 12:44:00

Key Events This Week

29 Dec 2025: Stock opens at Rs.446.85, declines 1.11%

30 Dec 2025: Further decline to Rs.437.40 (-2.11%)

31 Dec 2025: Coral Laboratories hits 52-week low of Rs.429

1 Jan 2026: Downgraded to Strong Sell by MarketsMOJO

2 Jan 2026: Stock rebounds to Rs.456.35 (+3.32%)

Week Open

Rs.446.85

Read full news article

Coral Laboratories Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals

2026-01-01 08:10:27

Coral Laboratories Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 31 Dec 2025. This revision reflects deteriorating financial performance, unfavourable valuation metrics, and a shift towards bearish technical indicators, signalling heightened risk for investors.

Read full news article

Coral Laboratories Ltd Stock Falls to 52-Week Low of Rs.429

2025-12-31 11:17:50

Coral Laboratories Ltd touched a fresh 52-week low of Rs.429 today, marking a significant decline amid ongoing challenges in its financial performance and market positioning. Despite a modest intraday recovery, the stock remains below all key moving averages, reflecting persistent downward pressure.

Read full news article

View All News